Coya Therapeutics, Inc. (COYA)
2.735
-0.08
(-2.67%)
USD |
NASDAQ |
Nov 06, 09:59
Coya Therapeutics Market Cap : 64.16M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 65.92M |
| November 04, 2026 | 72.25M |
| November 03, 2026 | 72.95M |
| November 02, 2026 | 75.77M |
| October 30, 2026 | 84.68M |
| October 29, 2026 | 93.36M |
| October 28, 2026 | 95.24M |
| October 27, 2026 | 96.65M |
| October 26, 2026 | 92.66M |
| October 23, 2026 | 92.42M |
| October 22, 2026 | 97.12M |
| October 21, 2026 | 97.12M |
| October 20, 2026 | 98.76M |
| October 19, 2026 | 98.52M |
| October 16, 2026 | 99.70M |
| October 15, 2026 | 101.81M |
| October 14, 2026 | 98.05M |
| October 13, 2026 | 104.97M |
| October 12, 2026 | 112.83M |
| October 09, 2026 | 116.12M |
| October 08, 2026 | 117.05M |
| October 07, 2026 | 115.18M |
| October 06, 2026 | 113.77M |
| October 05, 2026 | 113.77M |
| October 02, 2026 | 112.83M |
| Date | Value |
|---|---|
| October 01, 2026 | 110.96M |
| September 30, 2026 | 117.52M |
| September 29, 2026 | 117.99M |
| September 28, 2026 | 116.82M |
| September 25, 2026 | 119.17M |
| September 24, 2026 | 121.51M |
| September 23, 2026 | 118.23M |
| September 22, 2026 | 124.33M |
| September 21, 2026 | 116.12M |
| September 18, 2026 | 114.71M |
| September 17, 2026 | 111.66M |
| September 16, 2026 | 104.62M |
| September 15, 2026 | 109.08M |
| September 14, 2026 | 108.84M |
| September 11, 2026 | 102.75M |
| September 10, 2026 | 106.03M |
| September 09, 2026 | 108.14M |
| September 08, 2026 | 108.14M |
| September 04, 2026 | 111.66M |
| September 03, 2026 | 106.73M |
| September 02, 2026 | 103.68M |
| September 01, 2026 | 105.79M |
| August 31, 2026 | 106.97M |
| August 28, 2026 | 107.67M |
| August 27, 2026 | 114.00M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.125B |
| Oncolytics Biotech, Inc. | 56.65M |
| Sangamo Therapeutics, Inc. | 47.23M |
| Sarepta Therapeutics, Inc. | 1.885B |
| Anixa Biosciences, Inc. | 104.45M |
Market Cap Related Metrics
| PS Ratio | 7.143 |
| Price to Book Value | 1.483 |
| Price | 2.735 |
| Earnings Yield | -36.58% |